Phase II Trial of Neoadjuvant Carboplatin and Nab‐Paclitaxel in Patients with Triple‐Negative Breast Cancer

BACKGROUND: In this phase II clinical trial, we evaluated the efficacy of the nonanthracycline combination of carboplatin and nab‐paclitaxel in early stage triple‐negative breast cancer (TNBC). PATIENTS AND METHODS: Patients with newly diagnosed stage II–III TNBC (n = 69) were treated with neoadjuva...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncologist
Main Authors: Yuan, Yuan, Lee, Jin Sun, Yost, Susan E., Li, Sierra Min, Frankel, Paul H., Ruel, Christopher, Schmolze, Daniel, Robinson, Kim, Tang, Aileen, Martinez, Norma, Stewart, Daphne, Waisman, James, Kruper, Laura, Jones, Veronica, Menicucci, Andrea, Uygun, Sahra, Yoder, Erin, van der Baan, Bastiaan, Yim, John H., Yeon, Christina, Somlo, George, Mortimer, Joanne
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Inc. 2020
Assuntos:
Breast Cancer
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7930424/
https://ncbi.nlm.nih.gov/pubmed/33098195
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/onco.13574
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados